Abstract:
Ximenia Americana is considered one of medicinal plant which are
widely used especially in West of Sudan. This plant has been studied in
this research, which is collected from Nuba Mountains and Babanusa.
In part I of the present study, crude extracts of different parts of plant was
investigated for their biological activity. Preliminary investigations were
carried out to select the plant extracts of the highest activity for further
investigation. The extracts were screened for phytochemical constituents:
alkaloids, saponins, tannins, flavonoids, triterpenoids/sterols and
anthraquinones and assessed for their biological activities against four
Gram positive and Gram negative bacteria: Bacillus subtilis,
Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and
one fungi: Candida albicans by the agar diffusion method.
The second part of this study dealt with the evaluation of preliminary
screening and assessment results of the extracts. The Ximeniaamericana
bark was selected for further investigation based on its promising
biological activity. The bark material of the plant was extracted using
solvents with different polarities. The ethyl acetate extract of the bark
was selected for further fractionation based on antimicrobial activity
results.
Isolation of active compounds from the different extracts was carried out
using bioassay-guided fractionation. Selection of the active fractions for
further fractionation was carried out based on antimicrobial activity
results. Column chromatography monitored by TLC were used in
fractionation and isolation of pure compounds. Various techniques
including nuclear magnetic resonance (NMR), mass spectrometry (MS),
ultraviolet (UV), infrared (IR) spectrometry and GC/MS were used for
structure elucidation of the isolated compounds.
V
Column Chromatography has been done for ethyl acetate extract which
produced (22) semi- pured fractions, then bioactivity of these extracts has
been detected against previous bacteria and fungi, also they showed a
level of bioactivity especially fraction 16 and has been purified via thin
layer chromatography. Many compounds has been isolated and defined
via (GCMS) device to give the following compounds:
Phenol, 2, 4-bis (1,1- dimethylethyl) (C14H22O),
Methylhydroquinone,bis(trimethylsilyl) (C13H24O2Si2), 8-Octadecanone
(C18H26O), Benzocyclodecene,tetradecahydro (C14H26), n-
Heptadecyclocyclohexane (C23H46), Nonanoic acid, 9-oxo-,methyl ester
(C10H18O3), Phenol,2-4-bis(1,1-dimethylethyl) (C14H22O), Dodecanoic
acid, dimethyl ester (C13H26O2), Methyl tetradecanoate (C15H30O2), n-
Pentadecanol (C15H32O), n-Nonadecanol-1 (C19H40O), n-Tetracoanol-1
(C24H50O), 1-Nonadecene (C19H28), Triacontyl heptafluorobutyrate
(C34H61F7O2).
Toxicity of these extracts has been studied via “Brine shrimp lethality”
test, whereas study has showed that LD50 for Chloroform and ethyl acetate
are: 5.1817 μ g/ml and 16.3765 μ g/ml respectively, which confirm
toxicity of these extracts. Results show that these extracts have a
bioactivity in treatment of cancer.
The name and Structure elucidation of the pure compound zm4 from
fraction 16 Di-(2'-ethylhexyl)dihydro phthalate
Structure of Compound Zm4[Di-(2'-ethylhexyl)dihydro phthalate]